Source: Annual Congress 2006 - In vivo and in vitro aspects of lung injury
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Nishii, E. C. Gabazza, T. Takagi, T. Maruyama, H. Nakahara, H. Fujimoto, J. Maruyama, T. Kobayashi, H. Kobayashi, C. N. D‘Alessandro-Gabazza, O. Taguchi (Tsu, Japan). Vascular remodeling in the lung from mice treated with monocrotaline. The effect of protein C inhibitor transgenic expression. Eur Respir J 2006; 28: Suppl. 50, 4748

Member's Comments

No comment yet.

Related content which might interest you: Enhanced lung fibrosis in protein C inhibitor transgenic mice Source: Eur Respir J 2004; 24: Suppl. 48, 481s Year: 2004 Effect of anti-IL17 and/or Rho-kinase inhibitor treatments on vascular remodelling in an asthma model in mice Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 The effect of GM-CSF on lung maturation and parenchymal NOS expression in prenatally treated Balb/c mice Source: Eur Respir J 2005; 26: Suppl. 49, 341s Year: 2005 TGF-beta-dependent inhibitor of DNA protein (Id) expression in lung fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 521s Year: 2006 The effects of chronic hypoxia on pulmonary vascular reactivity in mice genetically deficient in connexin 43 Source: International Congress 2017 – Experimental PH Year: 2017 Alveolar type 2 cell dysfunction from expression of a surfactant protein C (SFTPC) mutation drives a fibrotic lung phenotype in mice Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017 Effect of proteinase inhibitor from crataeva tapia (cratabl) in distal lung mechanical, inflammatory and remodeling alterations induced by elastase in mice Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 The effect of bleomycin on the lungs of TGFβ1 transgenic mice Source: Eur Respir J 2001; 18: Suppl. 33, 80s Year: 2001 Aminoguanidine attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of heat shock protein 47 and TGF-β1 expression Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Heat shock protein 90 inhibitors block pulmonary fibrosis and dysfunction in HCl-exposed mice. Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis Year: 2017 Effect of eNOS gene overexpression on the vascular reactivity of isolated pulmonary arteries of chronic hypoxic rats Source: Annual Congress 2006 - Taormina 4th ERS Lung Science Conference "hypoxia in lung biology and disease" Year: 2006 Transcriptomic profiling of alveolar type 2 cells from mice expressing an ILD associated SFTPCI73T mutation supports their role in inflammatory cell recruitment and fibrotic lung remodeling. Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 Tenascin C knockout mice have an altered lung function at newborn and adult age Source: International Congress 2017 – Molecular pathways in lung development Year: 2017 Effect of NF-?B inhibitor IMD-1041 on BLM-induced pulmonary fibrosis in mice Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Resveratrol attenuates hypoxic pulmonary vascular remodeling in simulated high altitude-exposed rats: potential role of Hif-1α/NOX4/ROS inhibition Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Erythropoietin (EPO) attenuates the immunohistochemical expression of autophagy antibodies in bleomycin (BLM), induced pulmonary fibrosis (PF) in rats Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Premature aging in Zmpste24 deficient mice protects them from bleomycin induced lung fibrosis through upregulation of antifibrotic microRNAs Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 Disruption of Nrf2 enhances susceptibility to pulmonary fibrosis induced by bleomycin in mice Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Transgenic mice expressing a surfactant protein-B-urokinase-fusion protein in the distal respiratory epithelium show an attenuated fibrotic response to bleomycin-induced lung injury Source: Annual Congress 2005 - In vivo - approaches to lung injury Year: 2005